Success Metrics

Clinical Success Rate
96.1%

Based on 73 completed trials

Completion Rate
96%(73/76)
Active Trials
1(1%)
Results Posted
25%(18 trials)
Terminated
3(4%)

Phase Distribution

Ph phase_1
8
10%
Ph phase_2
6
8%
Ph phase_3
15
19%

Phase Distribution

8

Early Stage

6

Mid Stage

15

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
8(27.6%)
Phase 2Efficacy & side effects
6(20.7%)
Phase 3Large-scale testing
15(51.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

94.8%

73 of 77 finished

Non-Completion Rate

5.2%

4 ended early

Currently Active

1

trials recruiting

Total Trials

79

all time

Status Distribution
Active(2)
Completed(73)
Terminated(4)

Detailed Status

Completed73
Terminated3
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
79
Active
1
Success Rate
96.1%
Most Advanced
Phase 3

Trials by Phase

Phase 18 (27.6%)
Phase 26 (20.7%)
Phase 315 (51.7%)

Trials by Status

active_not_recruiting11%
completed7392%
not_yet_recruiting11%
terminated34%
withdrawn11%

Recent Activity

Clinical Trials (79)

Showing 20 of 79 trialsScroll for more
NCT06193863

An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure

Active Not Recruiting
NCT05900388

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

Not Yet Recruiting
NCT04979780

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Completed
NCT04174859

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Completed
NCT04356989

Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function

Completed
NCT05150938

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Completed
NCT03455439

Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)

Completed
NCT02864758

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

Completed
NCT02975453

Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban

Completed
NCT05022758

A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Completed
NCT03242278

Real-world Dosing Patterns of Rivaroxaban in the United States

Completed
NCT05112666

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Completed
NCT04923139

A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims Database

Completed
NCT01776424Phase 3

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Completed
NCT02558465

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Completed
NCT05461807

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Completed
NCT01606995

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation

Completed
NCT01442792Phase 2

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Completed
NCT04509193

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Completed
NCT03965741

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners

Completed

Drug Details

Intervention Type
DRUG
Total Trials
79